Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64.3M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
14.7M
-
Shares change
-
+197K
-
Total reported value, excl. options
-
$252M
-
Value change
-
+$4.17M
-
Number of buys
-
22
-
Number of sells
-
-10
-
Price
-
$17.35
Significant Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q3 2021
37 filings reported holding VERA - Vera Therapeutics, Inc. - COMMON STOCK as of Q3 2021.
Vera Therapeutics, Inc. - COMMON STOCK (VERA) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.7M shares
of 64.3M outstanding shares and own 22.87% of the company stock.
Largest 10 shareholders include FMR LLC (3.14M shares), Abingworth LLP (2.96M shares), Sofinnova Investments, Inc. (2.91M shares), CITADEL ADVISORS LLC (1.73M shares), KPCB XVI Associates, LLC (1.34M shares), Alphabet Inc. (945K shares), Octagon Capital Advisors LP (696K shares), BlackRock Inc. (314K shares), VANGUARD GROUP INC (246K shares), and JPMORGAN CHASE & CO (78.7K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.